company background image
TECN

Tecan Group SWX:TECN Stock Report

Last Price

CHF287.60

Market Cap

CHF3.7b

7D

6.4%

1Y

-40.1%

Updated

27 Jun, 2022

Data

Company Financials +
TECN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends0/6

TECN Stock Overview

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories.

Tecan Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tecan Group
Historical stock prices
Current Share PriceCHF287.60
52 Week HighCHF602.00
52 Week LowCHF264.60
Beta0.39
1 Month Change-8.47%
3 Month Change-23.18%
1 Year Change-40.06%
3 Year Change11.99%
5 Year Change60.31%
Change since IPO513.22%

Recent News & Updates

Jun 15
Should You Be Adding Tecan Group (VTX:TECN) To Your Watchlist Today?

Should You Be Adding Tecan Group (VTX:TECN) To Your Watchlist Today?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Shareholder Returns

TECNCH Life SciencesCH Market
7D6.4%4.9%3.8%
1Y-40.1%-25.2%-11.8%

Return vs Industry: TECN underperformed the Swiss Life Sciences industry which returned -24.7% over the past year.

Return vs Market: TECN underperformed the Swiss Market which returned -12.4% over the past year.

Price Volatility

Is TECN's price volatile compared to industry and market?
TECN volatility
TECN Average Weekly Movement6.5%
Life Sciences Industry Average Movement6.5%
Market Average Movement4.6%
10% most volatile stocks in CH Market7.6%
10% least volatile stocks in CH Market2.4%

Stable Share Price: TECN is more volatile than 75% of Swiss stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: TECN's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Swiss stocks.

About the Company

FoundedEmployeesCEOWebsite
19803,291Achim von Leoprechtinghttps://www.tecan.com

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions.

Tecan Group Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
TECN fundamental statistics
Market CapCHF3.66b
Earnings (TTM)CHF121.66m
Revenue (TTM)CHF946.62m

30.1x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TECN income statement (TTM)
RevenueCHF946.62m
Cost of RevenueCHF538.05m
Gross ProfitCHF408.57m
Other ExpensesCHF286.91m
EarningsCHF121.66m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 17, 2022

Earnings per share (EPS)9.56
Gross Margin43.16%
Net Profit Margin12.85%
Debt/Equity Ratio20.4%

How did TECN perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

28%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is TECN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for TECN?

Other financial metrics that can be useful for relative valuation.

TECN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.9x
Enterprise Value/EBITDA20.3x
PEG Ratio2.3x

Price to Earnings Ratio vs Peers

How does TECN's PE Ratio compare to its peers?

TECN PE Ratio vs Peers
The above table shows the PE ratio for TECN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average59x
BANB Bachem Holding
47.2x16.5%CHF5.4b
SFZN Siegfried Holding
28.3x12.1%CHF2.7b
PPGN PolyPeptide Group
47.6x15.3%CHF2.3b
SKAN SKAN Group
112.7x24.1%CHF1.2b
TECN Tecan Group
30.1x13.0%CHF3.7b

Price-To-Earnings vs Peers: TECN is good value based on its Price-To-Earnings Ratio (30.1x) compared to the peer average (59x).


Price to Earnings Ratio vs Industry

How does TECN's PE Ratio compare vs other companies in the European Life Sciences Industry?

Price-To-Earnings vs Industry: TECN is good value based on its Price-To-Earnings Ratio (30.1x) compared to the Swiss Life Sciences industry average (46.2x)


Price to Earnings Ratio vs Fair Ratio

What is TECN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TECN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio30.1x
Fair PE Ratio35.3x

Price-To-Earnings vs Fair Ratio: TECN is good value based on its Price-To-Earnings Ratio (30.1x) compared to the estimated Fair Price-To-Earnings Ratio (35.3x).


Share Price vs Fair Value

What is the Fair Price of TECN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TECN (CHF287.6) is trading below our estimate of fair value (CHF487.74)

Significantly Below Fair Value: TECN is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: TECN is poor value based on its PEG Ratio (2.3x)


Discover undervalued companies

Future Growth

How is Tecan Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


13.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TECN's forecast earnings growth (13% per year) is above the savings rate (-0.3%).

Earnings vs Market: TECN's earnings (13% per year) are forecast to grow faster than the Swiss market (6.1% per year).

High Growth Earnings: TECN's earnings are forecast to grow, but not significantly.

Revenue vs Market: TECN's revenue (8% per year) is forecast to grow faster than the Swiss market (4.2% per year).

High Growth Revenue: TECN's revenue (8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TECN's Return on Equity is forecast to be low in 3 years time (12.4%).


Discover growth companies

Past Performance

How has Tecan Group performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


19.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TECN has high quality earnings.

Growing Profit Margin: TECN's current net profit margins (12.9%) are lower than last year (14.2%).


Past Earnings Growth Analysis

Earnings Trend: TECN's earnings have grown by 19% per year over the past 5 years.

Accelerating Growth: TECN's earnings growth over the past year (17.3%) is below its 5-year average (19% per year).

Earnings vs Industry: TECN earnings growth over the past year (17.3%) underperformed the Life Sciences industry 50.8%.


Return on Equity

High ROE: TECN's Return on Equity (9.9%) is considered low.


Discover strong past performing companies

Financial Health

How is Tecan Group's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: TECN's short term assets (CHF671.9M) exceed its short term liabilities (CHF306.4M).

Long Term Liabilities: TECN's short term assets (CHF671.9M) exceed its long term liabilities (CHF464.9M).


Debt to Equity History and Analysis

Debt Level: TECN's net debt to equity ratio (0.7%) is considered satisfactory.

Reducing Debt: TECN's debt to equity ratio has increased from 0.6% to 20.4% over the past 5 years.

Debt Coverage: TECN's debt is well covered by operating cash flow (67.9%).

Interest Coverage: TECN's interest payments on its debt are well covered by EBIT (35.9x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Tecan Group current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.97%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: TECN's dividend (0.97%) isn’t notable compared to the bottom 25% of dividend payers in the Swiss market (1.99%).

High Dividend: TECN's dividend (0.97%) is low compared to the top 25% of dividend payers in the Swiss market (4.14%).


Stability and Growth of Payments

Stable Dividend: TECN is not paying a notable dividend for the Swiss market, therefore no need to check if payments are stable.

Growing Dividend: TECN is not paying a notable dividend for the Swiss market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: TECN is not paying a notable dividend for the Swiss market.


Cash Payout to Shareholders

Cash Flow Coverage: TECN is not paying a notable dividend for the Swiss market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average management tenure


CEO

Achim von Leoprechting (53 yo)

9.42yrs

Tenure

CHF3,141,000

Compensation

Dr. Achim Von Leoprechting, Ph D., has been Chief Executive Officer of Tecan Group Ltd., since April 1, 2019. He had been Head of the Partnering Business division at Tecan Group Ltd.since October 1, 2013...


CEO Compensation Analysis

Compensation vs Market: Achim's total compensation ($USD3.29M) is above average for companies of similar size in the Swiss market ($USD1.84M).

Compensation vs Earnings: Achim's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: TECN's management team is seasoned and experienced (6 years average tenure).


Board Members

Experienced Board: TECN's board of directors are considered experienced (9.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.9%.


Top Shareholders

Company Information

Tecan Group AG's employee growth, exchange listings and data sources


Key Information

  • Name: Tecan Group AG
  • Ticker: TECN
  • Exchange: SWX
  • Founded: 1980
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CHF3.659b
  • Shares outstanding: 12.72m
  • Website: https://www.tecan.com

Number of Employees


Location

  • Tecan Group AG
  • Seestrasse 103
  • Männedorf
  • Zurich
  • 8708
  • Switzerland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/27 00:00
End of Day Share Price2022/06/27 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.